The implementation of intravenous tissue plasminogen activator in acute ischaemic stroke - a scientific position statement from the National Stroke Foundation and the Stroke Society of Australasia

Christopher Levi; Richard Lindley; Brendon Smith; Christopher Bladin; Mark Parsons; Stephen Read; Dominique Cadilhac; Geoffrey Donnan; Stephen Davis; Graeme Hankey; Dennis Crimmins; Richard Gerraty; David Blacker; David Schultz; Rohan Grimley; Erin Lalor

doi:10.1111/j.1445-5994.2009.01938.x

The implementation of intravenous tissue plasminogen activator in acute ischaemic stroke - a scientific position statement from the National Stroke Foundation and the Stroke Society of Australasia

Christopher Levi, Richard Lindley, Brendon Smith, Christopher Bladin, Mark Parsons, Stephen Read, Dominique Cadilhac, Geoffrey Donnan, Stephen Davis, Graeme Hankey, Dennis Crimmins, Richard Gerraty, David Blacker, David Schultz, Rohan Grimley, Erin Lalor

Research output: Contribution to journal › Article › Research › peer-review

17 Citations (Scopus)

Original language	English
Pages (from-to)	317-324
Number of pages	8
Journal	Internal Medicine Journal
Volume	39
Issue number	5
DOIs	https://doi.org/10.1111/j.1445-5994.2009.01938.x
Publication status	Published - 2009
Externally published	Yes

Access to Document

10.1111/j.1445-5994.2009.01938.x

Cite this

Levi, C., Lindley, R., Smith, B., Bladin, C., Parsons, M., Read, S., Cadilhac, D., Donnan, G., Davis, S., Hankey, G., Crimmins, D., Gerraty, R., Blacker, D., Schultz, D., Grimley, R., & Lalor, E. (2009). The implementation of intravenous tissue plasminogen activator in acute ischaemic stroke - a scientific position statement from the National Stroke Foundation and the Stroke Society of Australasia. Internal Medicine Journal, 39(5), 317-324. https://doi.org/10.1111/j.1445-5994.2009.01938.x

@article{fa8d5d0235b4476694831a02077377f1,

title = "The implementation of intravenous tissue plasminogen activator in acute ischaemic stroke - a scientific position statement from the National Stroke Foundation and the Stroke Society of Australasia",

author = "Christopher Levi and Richard Lindley and Brendon Smith and Christopher Bladin and Mark Parsons and Stephen Read and Dominique Cadilhac and Geoffrey Donnan and Stephen Davis and Graeme Hankey and Dennis Crimmins and Richard Gerraty and David Blacker and David Schultz and Rohan Grimley and Erin Lalor",

year = "2009",

doi = "10.1111/j.1445-5994.2009.01938.x",

language = "English",

volume = "39",

pages = "317--324",

journal = "Internal Medicine Journal",

issn = "1444-0903",

publisher = "Wiley-Blackwell",

number = "5",

}

Levi, C, Lindley, R, Smith, B, Bladin, C, Parsons, M, Read, S, Cadilhac, D, Donnan, G, Davis, S, Hankey, G, Crimmins, D, Gerraty, R, Blacker, D, Schultz, D, Grimley, R & Lalor, E 2009, 'The implementation of intravenous tissue plasminogen activator in acute ischaemic stroke - a scientific position statement from the National Stroke Foundation and the Stroke Society of Australasia', Internal Medicine Journal, vol. 39, no. 5, pp. 317-324. https://doi.org/10.1111/j.1445-5994.2009.01938.x

The implementation of intravenous tissue plasminogen activator in acute ischaemic stroke - a scientific position statement from the National Stroke Foundation and the Stroke Society of Australasia. / Levi, Christopher; Lindley, Richard; Smith, Brendon et al.

In: Internal Medicine Journal, Vol. 39, No. 5, 2009, p. 317-324.

Research output: Contribution to journal › Article › Research › peer-review

TY - JOUR

T1 - The implementation of intravenous tissue plasminogen activator in acute ischaemic stroke - a scientific position statement from the National Stroke Foundation and the Stroke Society of Australasia

AU - Levi, Christopher

AU - Lindley, Richard

AU - Smith, Brendon

AU - Bladin, Christopher

AU - Parsons, Mark

AU - Read, Stephen

AU - Cadilhac, Dominique

AU - Donnan, Geoffrey

AU - Davis, Stephen

AU - Hankey, Graeme

AU - Crimmins, Dennis

AU - Gerraty, Richard

AU - Blacker, David

AU - Schultz, David

AU - Grimley, Rohan

AU - Lalor, Erin

PY - 2009

Y1 - 2009

U2 - 10.1111/j.1445-5994.2009.01938.x

DO - 10.1111/j.1445-5994.2009.01938.x

M3 - Article

VL - 39

SP - 317

EP - 324

JO - Internal Medicine Journal

JF - Internal Medicine Journal

SN - 1444-0903

IS - 5

ER -